Jun Huang

19PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Quantum information, computation and communicationCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T Cell Treatment Efficacy.

|Apr 26, 2026
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes.

|Feb 13, 2026
TCRγ constant usage tunes human γδ T cell antigen sensitivity, thymic programming, and peripheral function.

Mayuri Viswanathan, Caitlin D Castro, Augusta E Broughton

|Aug 20, 2025
A fluorescent-protein spin qubit.

Jacob S Feder, Benjamin S Soloway, Shreya Verma

|Jun 04, 2025
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.

Erting Tang, Yifei Hu, Guoshuai Cao

|May 06, 2025
Two-stage CD8<sup>+</sup> CAR T-cell differentiation in patients with large B-cell lymphoma.

Guoshuai Cao, Yifei Hu, Tony Pan

Pageof 4

Frequent Collaborators

6 joint publications

Yifei Hu

3 joint publications

Peter A Riedell

3 joint publications

Erting Tang

3 joint publications

Guoshuai Cao